Why the study?
Does rilmenidine effectively lower blood pressure and improve metabolic and cardiovascular risk factors in patients with hypertension?
Population
Patients with hypertension (general review)
Comparison
Rilmenidine vs Other first-line antihypertensive drugs
Design
Review
Authors
Loading...
May support use in hypertension with metabolic concerns; leaves open need for outcome trials.
Does rilmenidine effectively lower blood pressure and improve metabolic and cardiovascular risk factors in patients with hypertension?
Rilmenidine is an effective antihypertensive agent with favorable metabolic and target-organ effects, though long-term cardiovascular outcome data are lacking.
Joanne Reid (2001) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: